Concepedia

Author

Eric L. Simpson

Oregon Health & Science UniversityORCID

Also Known As

E Saunders, E Simpson, E. L. Simpson, E. Simpson, E.L Simpson, E.L. Simpson, Ellie Simpson, Eric L Simpson, Eric L. Simpson, Eric Lawrence Simpson

554

Publications

21.9K

Citations

74

H-Index

90

Concepts

All Affiliations

Oregon Health & Science UniversityGeorge Washington UniversityRegeneron (United States)Icahn School of Medicine at Mount SinaiNorthwestern University
EL

About

Eric L. Simpson is an author at Oregon Health & Science University specializing in dermatology, medicine, and allergy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

41

5.1K

2

Allergy

17

24

2.9K

3

Public Health

3

3

69

4

Engineering

1

1

159

5

Health Sciences

1

1

11

Eric L. Simpson

×

150

Publications

18.2K

Citations

63

H-Index

YearCitations

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky,

New England Journal of Medicine

2016

2K

Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health

Tatyana Shaw, Gabriel P. Currie, Caroline Koudelka,

Journal of Investigative Dermatology

2010

719

Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention

Eric L. Simpson, Joanne R Chalmers, Jon M. Hanifin,

Journal of Allergy and Clinical Immunology

2014

708

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

Andreas Wollenberg, Andrew Blauvelt, Emma Guttman‐Yassky,

British Journal of Dermatology

2020

553

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

Amy S. Paller, Wynnis L. Tom, Mark Lebwohl,

Journal of the American Academy of Dermatology

2016

545

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Emma Guttman‐Yassky, Henrique D. Teixeira, Eric L. Simpson,

The Lancet

2021

502

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried,

JAMA Dermatology

2019

479

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Eric L. Simpson, Rodney Sinclair, Seth Forman,

The Lancet

2020

452

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis

Andrew Blauvelt, Henrique D. Teixeira, Eric L. Simpson,

JAMA Dermatology

2021

451

Mental health comorbidity in patients with atopic dermatitis

Pouya Yaghmaie, Caroline Koudelka, Eric L. Simpson

Journal of Allergy and Clinical Immunology

2012

439

Page 1